HCA

HCA Healthcare, Inc. - 10-Q Summary (Period Ended Sept 30, 2003)

Business Context and Reporting Period

This is an unaudited quarterly report (Form 10-Q) for HCA Inc., a holding company owning and operating hospitals and related health care entities. The report covers the quarter and nine months ended September 30, 2003. As of this date, HCA affiliates operated 183 hospitals and 78 freestanding surgery centers across 23 U.S. states, England, and Switzerland. The company operates in a single line of business: operating hospitals and related health care entities.

Key Financial Metrics

Margins: Net income margin for the quarter was 5.6% (up from 4.1% in 2002). For the nine months, the margin was 6.3% (down slightly from 6.4% in 2002).

Material Changes vs. Prior Period

• Revenue Growth: Revenues increased 11.0% for the quarter and 10.2% for the nine months. This growth was driven by a 6.9% increase in same-facility revenues (due to rate increases) and the inclusion of the Health Midwest acquisition (11 hospitals in Kansas City), which contributed $232 million in quarterly revenue.
• Profitability: Net income rose 52.9% for the quarter and 8.6% for the nine months. The quarter-over-quarter improvement was significantly aided by the absence of a $168 million impairment charge on investment securities recorded in Q3 2002.
• Bad Debt Provision: The provision for doubtful accounts increased significantly, rising to 10.3% of revenues in Q3 2003 from 8.3% in Q3 2002. This reflects a deterioration in the collectability of self-pay/uninsured accounts due to economic conditions.
• Acquisitions and Dispositions: HCA acquired 11 hospitals for a net cash outlay of $895 million in the first nine months of 2003. Conversely, the company recognized an $85 million pretax gain on the sale of facilities during the same period.
• Impairment Charges: In Q2 2003, HCA recorded a $130 million pretax charge for the impairment of long-lived assets related to the discontinuation of an internal patient accounts receivable management system.

Guidance, Outlook, Risks, and Unusual Items

• Government Settlements: HCA resolved major government investigations in 2003. In Q2, it paid $250 million to CMS. In Q3, it paid $641 million to the DOJ and $17.7 million to state Medicaid agencies. These payments significantly impacted cash flow but resolved long-standing liabilities.
• Shareholder Litigation: HCA reached a preliminary understanding to settle 1997 class action securities lawsuits for $49.5 million, with insurance carriers expected to cover the majority of the cost.
• Outlook and Risks:
  • Volume Trends: Same-facility admissions were flat (0.2% increase) in Q3, while outpatient surgeries declined 2.5% on a same-facility basis due to competition and physician malpractice insurance issues.
  • Medicare Outliers: Management estimates that CMS regulatory changes effective October 1, 2003, could reduce monthly revenue from Medicare operating outlier payments by up to $12 million.
  • Capital Expenditures: Planned capital expenditures are projected at $1.8 billion for 2004 and $1.6 billion for 2005. The company also committed to spending $450 million on capital improvements for the Health Midwest system over five years.
  • Dividend Policy: Management is evaluating a change to the existing dividend policy, with an announcement expected in Q1 2004.
• Unusual Items: The financial results for the nine months ended Sept 30, 2003, included a $130 million impairment charge for long-lived assets and an $85 million gain on facility sales. The prior year period included a $168 million impairment of investment securities.

Investor Verification Checklist

• Bad Debt Trends: Verify the sustainability of the 10.3% provision for doubtful accounts and the impact of the new sliding-scale discount policy for uninsured patients.
• Medicare Reimbursement: Monitor the actual impact of the CMS outlier payment regulation changes expected to reduce revenue by up to $12 million monthly.
• Integration of Health Midwest: Assess the financial performance and integration progress of the 11 acquired Kansas City hospitals, which reported a net loss of $6 million in Q3.
• Debt Levels: Review the increase in long-term debt to $8.278 billion and the company's ability to service this debt given the high capital expenditure requirements.
• Legal Contingencies: Confirm the final approval of the $49.5 million shareholder settlement and the status of the ongoing SEC investigation dating back to 1997.